about
Science review: carnitine in the treatment of valproic acid-induced toxicity - what is the evidence?Valproic acid-induced hyperammonemia and thrombocytopenia in an elderly woman.The role of carnitine supplementation during valproic acid therapy.Plasma and hepatic carnitine and coenzyme A pools in a patient with fatal, valproate induced hepatotoxicity.Levocarnitine and dialysis: a review.Case files of the Children's Hospital of Michigan Regional Poison Control Center: the use of carnitine for the management of acute valproic acid toxicity.Hyperammonemic encephalopathy caused by carnitine deficiency.Valproic Acid and topiramate induced hyperammonemic encephalopathy in a patient with normal serum carnitineCarnitine in the treatment of valproic acid-induced toxicity.Carnitine, valproate, and toxicity.Biochemical relationships between Reye's and Reye's-like metabolic and toxicological syndromes.Comparison of serum carnitine levels and clinical correlates between outpatients and acutely hospitalised individuals with bipolar disorder and schizophrenia: A cross-sectional study.Valproate-associated hepatotoxicity and its biochemical mechanisms.L-Carnitine.Short-term effects of administration of anticonvulsant drugs on free carnitine and acylcarnitine in mouse serum and tissues.Doxorubicin toxicity can be ameliorated during antioxidant L-carnitine supplementation.Serum and muscle carnitine levels in epileptic children receiving sodium valproate.Clinical correlates of low serum carnitine levels in hospitalized psychiatric patients.A child with valproic acid-associated carnitine deficiency and carnitine-responsive cardiac dysfunction.Should Pharmacies Be Included in Medication Reconciliation? A Report of Recurrent Valproic Acid Toxicity.
P2860
Q24813193-410190A1-8256-4BC6-8486-55179259D0C0Q33362174-813616CA-E688-4DA8-82EE-4224BD62D45FQ33941948-5A28D327-1B36-4862-8089-32982230E1E8Q34408675-795A8B89-0403-4537-8241-433D2BFFF463Q36278353-C01C4558-E863-419F-BD32-592DFD66656BQ36548488-32DE5223-53C5-4C15-8EBD-E8977D0C43FFQ36607259-A25B3F1C-FAD2-4FCC-807C-65C3B998D56DQ36891327-976C7834-302E-47F1-B278-2FA3DBBC0F6FQ37413086-F66C49E1-296E-474A-8547-F58F9CA6C9ADQ37659363-301CD0CB-19C9-4B4D-88EB-F07106DBEDF8Q38682728-7EF90A43-110C-44A9-90D6-55558BB49C8DQ38879830-9C063E03-888C-4594-A54C-F7BA65F16D10Q39602947-E76489FE-B4A6-4C1B-A3E1-8D0F1E4E87DDQ41075851-FD88197B-7D14-4A58-A2A2-6CCD4C0E6B9EQ41159241-9A9F91EB-74F4-4886-B9E8-CA6ED0711A14Q42646273-1FCA32D0-5E26-457C-B952-62549DD6F50AQ46147751-06836546-A0EF-4B88-A571-DF2609D5CD1BQ51848860-4314AAA9-B057-4542-B50E-B9D70695B816Q52229942-8E4F82BB-142C-4051-A85E-62CFEED68EDEQ55024054-79E0AB80-EDD1-421B-85DD-614DFB44BE48
P2860
description
1986 nî lūn-bûn
@nan
1986年の論文
@ja
1986年学术文章
@wuu
1986年学术文章
@zh
1986年学术文章
@zh-cn
1986年学术文章
@zh-hans
1986年学术文章
@zh-my
1986年学术文章
@zh-sg
1986年學術文章
@yue
1986年學術文章
@zh-hant
name
Serum carnitine during valproic acid therapy.
@en
Serum carnitine during valproic acid therapy.
@nl
type
label
Serum carnitine during valproic acid therapy.
@en
Serum carnitine during valproic acid therapy.
@nl
prefLabel
Serum carnitine during valproic acid therapy.
@en
Serum carnitine during valproic acid therapy.
@nl
P2093
P2860
P1433
P1476
Serum carnitine during valproic acid therapy.
@en
P2093
Paetzke-Brunner I
P2860
P304
P356
10.1111/J.1528-1157.1986.TB03584.X
P577
1986-09-01T00:00:00Z